vs
Side-by-side financial comparison of Cambium Networks Corp (CMBM) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $20.6M, roughly 2.0× Entrada Therapeutics, Inc.). Cambium Networks Corp runs the higher net margin — -17.9% vs -84.4%, a 66.5% gap on every dollar of revenue. On growth, Cambium Networks Corp posted the faster year-over-year revenue change (-23.2% vs -65.2%). Cambium Networks Corp produced more free cash flow last quarter ($-10.8M vs $-39.7M). Over the past eight quarters, Entrada Therapeutics, Inc.'s revenue compounded faster (6.4% CAGR vs -27.2%).
Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
CMBM vs TRDA — Head-to-Head
Income Statement — Q4 FY2024 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.3M | $20.6M |
| Net Profit | $-7.2M | $-17.3M |
| Gross Margin | 36.6% | — |
| Operating Margin | -28.4% | -106.0% |
| Net Margin | -17.9% | -84.4% |
| Revenue YoY | -23.2% | -65.2% |
| Net Profit YoY | 71.0% | -173.8% |
| EPS (diluted) | $-0.26 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 25 | — | $20.6M | ||
| Q4 24 | $40.3M | $37.4M | ||
| Q3 24 | $44.7M | $19.6M | ||
| Q2 24 | $45.2M | $94.7M | ||
| Q1 24 | $47.1M | $59.1M | ||
| Q4 23 | $52.5M | $41.8M | ||
| Q3 23 | $44.6M | $43.7M | ||
| Q2 23 | $53.7M | $18.2M |
| Q1 25 | — | $-17.3M | ||
| Q4 24 | $-7.2M | $1.1M | ||
| Q3 24 | $-34.5M | $-14.0M | ||
| Q2 24 | $-14.2M | $55.0M | ||
| Q1 24 | $-18.4M | $23.5M | ||
| Q4 23 | $-24.9M | $-9.5M | ||
| Q3 23 | $-36.4M | $35.5M | ||
| Q2 23 | $-13.4M | $-25.9M |
| Q1 25 | — | — | ||
| Q4 24 | 36.6% | — | ||
| Q3 24 | 43.6% | — | ||
| Q2 24 | 32.5% | — | ||
| Q1 24 | 29.8% | — | ||
| Q4 23 | 15.2% | — | ||
| Q3 23 | 26.7% | — | ||
| Q2 23 | 39.0% | — |
| Q1 25 | — | -106.0% | ||
| Q4 24 | -28.4% | -15.7% | ||
| Q3 24 | -69.6% | -110.7% | ||
| Q2 24 | -27.2% | 56.4% | ||
| Q1 24 | -33.1% | 35.7% | ||
| Q4 23 | -44.5% | 11.7% | ||
| Q3 23 | -46.2% | 32.0% | ||
| Q2 23 | -20.9% | -89.7% |
| Q1 25 | — | -84.4% | ||
| Q4 24 | -17.9% | 3.0% | ||
| Q3 24 | -77.3% | -71.7% | ||
| Q2 24 | -31.5% | 58.1% | ||
| Q1 24 | -39.2% | 39.7% | ||
| Q4 23 | -47.5% | -22.8% | ||
| Q3 23 | -81.5% | 81.1% | ||
| Q2 23 | -25.0% | -142.7% |
| Q1 25 | — | $-0.42 | ||
| Q4 24 | $-0.26 | $-0.20 | ||
| Q3 24 | $-1.22 | $-0.35 | ||
| Q2 24 | $-0.51 | $1.55 | ||
| Q1 24 | $-0.66 | $0.68 | ||
| Q4 23 | $-0.90 | $-0.23 | ||
| Q3 23 | $-1.32 | $1.02 | ||
| Q2 23 | $-0.49 | $-0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $67.8M |
| Total DebtLower is stronger | $67.6M | — |
| Stockholders' EquityBook value | $-3.2M | $417.3M |
| Total Assets | $173.7M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 25 | — | $67.8M | ||
| Q4 24 | — | $101.2M | ||
| Q3 24 | — | $78.0M | ||
| Q2 24 | — | $185.3M | ||
| Q1 24 | — | $68.4M | ||
| Q4 23 | — | $67.6M | ||
| Q3 23 | — | $51.9M | ||
| Q2 23 | — | $79.7M |
| Q1 25 | — | — | ||
| Q4 24 | $67.6M | — | ||
| Q3 24 | $67.6M | — | ||
| Q2 24 | $68.9M | — | ||
| Q1 24 | $63.8M | — | ||
| Q4 23 | $25.1M | — | ||
| Q3 23 | $25.8M | — | ||
| Q2 23 | $26.4M | — |
| Q1 25 | — | $417.3M | ||
| Q4 24 | $-3.2M | $428.7M | ||
| Q3 24 | $1.9M | $422.4M | ||
| Q2 24 | $34.1M | $429.9M | ||
| Q1 24 | $45.0M | $269.4M | ||
| Q4 23 | $61.1M | $242.4M | ||
| Q3 23 | $82.5M | $246.7M | ||
| Q2 23 | $116.5M | $206.9M |
| Q1 25 | — | $486.5M | ||
| Q4 24 | $173.7M | $526.3M | ||
| Q3 24 | $194.3M | $554.6M | ||
| Q2 24 | $221.1M | $582.0M | ||
| Q1 24 | $219.8M | $510.8M | ||
| Q4 23 | $209.1M | $469.2M | ||
| Q3 23 | $222.4M | $485.0M | ||
| Q2 23 | $275.7M | $494.0M |
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 36.12× | — | ||
| Q2 24 | 2.02× | — | ||
| Q1 24 | 1.42× | — | ||
| Q4 23 | 0.41× | — | ||
| Q3 23 | 0.31× | — | ||
| Q2 23 | 0.23× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.4M | $-38.5M |
| Free Cash FlowOCF − Capex | $-10.8M | $-39.7M |
| FCF MarginFCF / Revenue | -26.8% | -192.9% |
| Capex IntensityCapex / Revenue | 1.1% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-21.4M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 25 | — | $-38.5M | ||
| Q4 24 | $-10.4M | $-31.6M | ||
| Q3 24 | $8.9M | $-24.3M | ||
| Q2 24 | $2.4M | $39.8M | ||
| Q1 24 | $-15.9M | $-25.5M | ||
| Q4 23 | $-5.8M | $-4.0M | ||
| Q3 23 | $-345.0K | $-24.5M | ||
| Q2 23 | $-4.5M | $-35.1M |
| Q1 25 | — | $-39.7M | ||
| Q4 24 | $-10.8M | $-32.2M | ||
| Q3 24 | $6.8M | $-24.9M | ||
| Q2 24 | $87.0K | $38.8M | ||
| Q1 24 | $-17.4M | $-26.4M | ||
| Q4 23 | $-7.4M | $-5.0M | ||
| Q3 23 | $-1.5M | $-25.9M | ||
| Q2 23 | $-5.2M | $-36.6M |
| Q1 25 | — | -192.9% | ||
| Q4 24 | -26.8% | -86.2% | ||
| Q3 24 | 15.2% | -127.3% | ||
| Q2 24 | 0.2% | 41.0% | ||
| Q1 24 | -37.0% | -44.6% | ||
| Q4 23 | -14.0% | -11.9% | ||
| Q3 23 | -3.3% | -59.3% | ||
| Q2 23 | -9.7% | -201.5% |
| Q1 25 | — | 5.6% | ||
| Q4 24 | 1.1% | 1.7% | ||
| Q3 24 | 4.8% | 3.3% | ||
| Q2 24 | 5.1% | 1.1% | ||
| Q1 24 | 3.3% | 1.4% | ||
| Q4 23 | 3.1% | 2.3% | ||
| Q3 23 | 2.5% | 3.3% | ||
| Q2 23 | 1.2% | 8.4% |
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | -0.69× | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
TRDA
Segment breakdown not available.
